Revelation Biosciences, Inc. (REVB)

NCM – Real Time Price. Currency in USD

1.04

+0.06 (6.31%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-27K

-28K

-25K

-40K

Gross Profit

-27K

-28K

-25K

-40K

Operating expenses (excl. COGS)

-9M

-8M

-9M

-11M

Operating Income

-9M

-8M

-9M

-11M

Non-operating income, total

157K

-7M

35K

Pretax income

-9M

-15M

-120K

-11M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-9M

-15M

-120K

-11M

Revelation Biosciences, Inc. (REVB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Revelation Biosciences, Inc. (REVB)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Revelation Biosciences, Inc. (REVB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Revelation Biosciences, Inc. (REVB)

Income Statement (Annual)

Income Statement (Annual)